Tagged with Pharma

Austria Martin Prinz, CTO of Croma-Pharma, a family-owned Austrian aesthetic dermatology company, discusses the evolution of the company over the years and their specialist, ever-expanding portfolio. Additionally, he documents the role of training clinics in establishing a vertical business model and provides an overview of the company’s growing global reach, namely…

Austria Mario Huber, general manager of PharmaMar Austria, a multinational and an innovative oncology-based Spanish company, discusses the growth of the company in Austria and the reasons behind the success of Yondelis®, the company’s flagship product. Furthermore, he provides an overview of the clinical trials the Austrian affiliate is undertaking and…

Canada Dr. Fernand Labrie shares the significant achievements of Endoceutics, in launching its first breakthrough product for post-menopausal vulvar and vaginal atrophy, known as the ‘female Viagra’, the innovations behind the specialty area of ‘intracrinology’ that he discovered, and his perspective on the importance of homegrown innovation for Canada’s development. Having…

India The secretary-general of the Indian Drug Manufacturers Association (IDMA) gives his insight into the current state of the Indian pharma industry, the IDMA’s role in raising the quality of Indian-made products, and the country’s vital role in the global supply chain. IDMA is celebrating its 55th anniversary in India and…

Brazil Haig Yeghiaian, country manager of LEO Pharma Brazil, details his strategic mission and objectives since he took over the helm of the affiliate in November 2016 as well as the key opportunities and structural rooms for improvement he identifies within the promising Brazilian dermatology area, before highlighting how he wants…

Tunisia Senda Bahri Hicheri, director of the National Control Laboratory of Tunisia (LNCM), is looking forward to helping Tunisian pharmaceutical players thrive by allowing them to profit from both shorter market access times and an upcoming accreditation for the laboratory. In this interview, she explains the key role the LNCM is…

Switzerland Saad Harti, president of Legacy Healthcare, discusses the company’s origins, their unique focus on side-effect free botanical drugs for chronic conditions, and the importance of stakeholder education in this exciting but still immature field.   Most of our current emphasis is on alleviating side effects of cancer treatments, also called…

Austria Bernd Grabner, board member of Jacoby GM pharma, a leading Austrian wholesaler, provides an in-depth look into the historical merger of family owned Jacoby, GM pharma and Kӧgl Pharma as well as the moves being made to bolster a vertically integrated business model. Furthermore, he gives an overview of the…

Austria Barbara Fritsche-Surchat, general manager of Servier Austria, a leading innovative French company looking to bolster its global oncology presence, provides an in-depth analysis of the balancing act between pricing and market access in the Austrian healthcare system as well as how the company’s global oncology vision has influenced Austrian operations.…

Bulgaria Dr. Atanas Atanasov, country manager at Angelini Bulgaria, explains the affiliate’s growth to become a top ten player in the Bulgarian industry and highlights the leadership position of its portfolio in each category based on a long-term promotion strategy and value-based quality. Angelini started its internationalisation process ten years ago,…

Canada Dr. Jeremy B. Desai, CEO & President of Apotex, the Canadian international generics powerhouse, discusses his mandate in 2014 to take the company global, the challenges and opportunities of increasing convergence between the generics, branded and biosimilars sectors globally, and the main growth engines for Apotex looking forward. Jeremy, you…

Austria Bernhard Wittmann, managing director of Sigmapharm and MoNo, discusses the company’s product portfolio and the diverse tailored services for their partners. Furthermore, he provides an in-depth look into MoNo’s new 20 million EUR (24 million USD) CMO production plant that will be completed in 2019. The ten-fold increase in capacity…